Comparative Analysis of Statistical Models for Epilepsy Incidence
DOI:
https://doi.org/10.26437/ajar.v10i2.821Keywords:
Epilepsy. demographic. geometric distribution. poison distribution. zero-inflated poisonAbstract
Purpose: The paper aims to identify the best-fit trajectory model among selected model candidates on the epilepsy dataset, emphasising time and demographic factors.
Design/Methods/Approach: The study employed secondary monthly count data from the District Health Information Management System-2 (DHIMS-2) of the Ghana Health Service. The data was analysed using zero-inflated Poisson (ZIP) regression, zero-inflated negative binomial (ZINB) regression, and geometric regression (GR) models. These models were evaluated based on their goodness-of-fit to the dataset.
Findings: The geometric regression (GR) model emerged as the best-fit model compared to the ZIP and ZINB models. The results revealed that epilepsy incidence in the Saboba District is sex-dependent, with a significant p-value of 0.0369. Furthermore, the study found that epilepsy prevalence is relatively lower in younger children (0-9 years) and older adults (60-70+ years). Participants within the economically active age group (18-59 years) were found to be at the highest risk. Moreover, the year 2015 recorded the highest epilepsy incidence, while 2013 had the lowest.
Research Limitation: The study solely used a dataset from the Saboba District, Ghana. As a result, its conclusion may not be broadly applicable.
Practical implications: The study provides crucial information for healthcare policymakers to develop targeted interventions for epilepsy. It emphasizes the need to protect the rights of people living with Epilepsy (PLWE), integrate risk factors into outreach programs, and improve access to healthcare services. These findings can help health systems incorporate better treatment and care strategies for high-risk populations.
Social implications: The study highlights the significant social impact of epilepsy, particularly on the economically active population. It stresses the importance of addressing the stigma and discrimination faced by PLWE through public education and awareness campaigns.
Originality /value: This study uses advanced statistical models to offer a vigorous methodological lens for analysing epilepsy data, thus supporting future research and policy development in mental health and epilepsy management in Ghana and beyond.
References
Adeloye, R., Paul, A., George-Carey, D., Kolčić, I., Grant, L., & Chan, K. Y. (2012). An
estimate of the prevalence of epilepsy in sub-Saharan Africa: a systematic analysis. J. Glob. Health, 1–13
Ae-Ngibise, K.A., Akpalu, B., Ngugi, A., Akpalu, A., Agbokey, F. & Adjei, P. (2015). Prevalence
and risk factors of active convulsive epilepsy in Kintampo, Ghana. Pan Afr. Med. J.
Akpalu A., Adjei P., Nkromah K., Poku, F.O. & Sarfo, F.S. (2021). Neurological disorders
encountered at an out-patient clinic in Ghana's largest medical center: A 16-year review. eNeurologicalSci.
Asare, J. B., Robert, M., Mogan, C., Adjase, E. T., & Osei, A. (2013). Mental Health System in
Ghana. Accra: Ministry of Health & Kintampo Project, Kintampo, Ghana.WHO, https://www.afro.who.int/countries/ghana/publication/who-aims-report-mental-health-system-ghana
Ayilara, O. O. (2010). Social consequences of epilepsy: A study of 231 Nigerian patients. Annals
of African Medicine, 9(3), 170–175
Ba-Diop, A., Marin, B., Druet-Cabanac, M., Ngoungou, E.B., Newton, C. R. & Preux, P. M.
(2014). Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa. Lancet Neurol., vol. 13, pp. 1029–1044
Bastaki, S., Bastaki, S. M.A., Shehab, F. K., & Bastaki, A. A. (2024). Anticonvulsant effects of
the histamine H3 receptor antagonist DL76. Epilepsy Research, 195(2)
Bauer, S., & Chen, Z. (2024). Innovative non-invasive brain stimulation for epilepsy treatment:
Current state and future directions. Frontiers in Neurology, 14, 1135587
Blank, L. J. & Jette, N. (2023). Epilepsy research in 2022: clinical advances. Lancet Neurology.
Beghi, E., Giussani, G., Nichols, E., Sander, J. W., & Wheless, J. W. (2019). Global, regional, and
national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(4), 357-375
Canet, E., Gaultier, C., & Dehan, M. (2022). Effects of sleep deprivation on respiratory events
during sleep in patients with epilepsy. Journal of Applied Physiology, 66, 1158–1163.
Chen, C.C., Chen, L.S., Yen, M.F., Chen, H.H. & Liou, H.H. (2012). Geographic variation in the
age- and sex-specific prevalence and incidence of epilepsy: Analysis of Taiwanese National Health Insurance-based data. Epilepsia, 53(2),283–290
Cui, Z., Liao, C., Li, H., & Chen, F. (2022). Management of acute seizures in children with
epilepsy: Knowledge, attitudes, and practices among Chinese families. Frontiers in Neurology
Davis, A. J., & Wallis, L. A. (2020). Impact of flood disasters on health: Learning from clinical
practice. Australasian Emergency Care, 23(3), 122–129
D'Ardenne, K., Soltesz, I., & Buch, V. (2024). Identification of novel targets for epilepsy
treatment: The role of the fasciola cinereum. Stanford Medicine News CenteDeegbe, D. A. (2021). Self-efficacy in seizure management is differentially correlated with quality of life in persons with epilepsy, depending on seizure recurrence and stigma. Epilepsy Behav., 12(2), 1–19, 2021
Deegbe, D.A., Aziato, L., & Attiogbe, A. (2019). Beliefs of people living with epilepsy in the
Accra Metropolis, Ghana. Seizure, 73, 21–25, 2019
Degiorgio, C. M., Curtis, A., Carapetian, A., Hovsepian, D., Krishnadasan, A., & Markovic, A.
(2020). Why are epilepsy mortality rates rising in the United States? Population-based multiple cause-of-death study. BMJ Open, 10(8),1–6
D'Souza, W. J., Quinn, S. J., Fryer, J. L., & O’Brien, T. J. (2023). Prevalence and demographic
distribution of treated epilepsy in a community-based study. Acta Neurologica Scandinavica, 147(3), 165–172
Eadie, M.J. & Bladin, P.F. (2010). The idea of epilepsy as a disease per Se. J. Hist. Neurosci.,
(3), 209–220
Fadaie, E., Chen, Z., Ademi, Z., Liew, D., & Kwan, P. (2020). The costs of epilepsy in Australia:
A productivity-based analysis. Neurology, 95(24)
Fiest, K. M., Sauro, K. M., Patten, S. B., & Wiebe, S. (2022). Prevalence and incidence of epilepsy:
A meta-analysis. Neurology, 99(6), 563–570
Fisher, R. S., Bogacz, A., Cross, J. H., & Elger, C. E. (2022). Practical clinical definition of
epilepsy. Epilepsia, 63(5), 475–482
Freidel, R., Mamad, O., Riva, A., & Antonella, P. (2024). Advances in drug-resistant temporal
lobe epilepsy: Exploring novel therapies. Neurology & Epilepsy, 19(1), 25-31
Ghanean, H, Nojomi, M., & Jacobsson, L. (2013). Public awareness and attitudes towards epilepsy
in Tehran, Iran. Glob. Health Action, 6, 21618
Chan, M., Wong, T. C. H., Weichard, A., Nixon, G. M., Walter, L. M., & Horne, R. S. C. (2022).
Sleep macro-architecture and micro-architecture in children with epilepsy. Pediatric Research, 87, 703–710
Gonçalves, E., Mendes-Lopes, N. &. Silva F. (2016). Zero-inflated compound Poisson
distributions in integer-valued GARCH models. Statistics (Ber)., 50(3), 558–578
Gupta, S. K., Margolis, S. K., Grant, A.C. Gonzalez, J.S. & Nakhutina, L. (2021). Relationships
among illness representations and depressive symptom severity in predominantly African-American and Caribbean-American people withepilepsyy. Clin. Neuropsychol., 1–17, 2021
Herron, J. L., & Kilpatrick, C. J. (2023). Drug-resistant epilepsy: Understanding the neurobiology
to enhance treatment strategies. Seizure, 116, 29-36
Henshall, D. C. (2023). Epigenetic mechanisms in epilepsy: Progress and challenges for
therapeutic development. Nature Reviews Neurology, 19(3), 146-158
Hilbe, J.M. (2014). Zero-inflated Negative Binomial Regression. Model. Count Data, pp. 126–
, 2014.
Issa, N. P., Nunn, K. C., Wu, S., Haider, H. A., & Tao, J. X. (2023). Putative roles for homeostatic
plasticity in epileptogenesis. Epilepsia, 64(3), 539–552
Kaculini, C. M., Tate-Looney, A. J. & Seifi, A. (2021). The history of epilepsy: From ancient
mysteries to modern misconceptions. Cureus, 13(3)
Kamo, K. I., Yanagihara, H., & Satoh, K. (2013). Bias-corrected AIC for selecting variables in
poisson regression models. Commun. Stat. - Theory Methods, 42(11), 1911–1921
Khan, S. A., & Mughal, M. N. (2018). Awareness and prevalence of epilepsy; a study in
educational hubs at Sheringal, Khyber Pakhtunkhwa, Pakistan. ARC Journal of Neuroscience, 3(1), 17-24
Kim, H., Baek, H., & Lee, D. S. (2024). Neuromodulation techniques in epilepsy: Current trends
and therapeutic efficacy. Frontiers in Neuroscience
Kim, H., & Lee, J. (2023). Advances in epilepsy surgery: Exploring the fasciola cinereum’s role
in seizure onset and propagation. Nature Medicine
Lauren, B.S. (2018). Assessment of depression in epilepsy: The utility of common and disease-
specific self-report depression measures. Taylor Fr. Gr. (Multi-Disciplinary)
Magano, G., & Kandjimi, K. (2015). The impact of flooding on people living with HIV: A case
study from the Ohangwena Region, Namibia. Global Health Action, 8, 26862
Magiorkinis, E., Diamantis, A., Sidiropoulou, K., & Panteliadis, C. (2014). Highlights in the
History of Epilepsy: The Last 200 years. Epilepsy Res. Treat., 1–13
Mendoza, N. V. R., Ortega, E. M. M. & Cordeiro, G. M. (2014). The exponentiated-log-logistic
geometric distribution: Dual activation. Commun. Stat. - Theory Methods, 45(13), 3838–3859
Mesraoua B. (2020). Dramatic outcomes in epilepsy: depression, suicide, injuries, and mortality.
Curr. Med. Res. Opin., 36(9),1473–1480
Mhlari, R. M. & Sodi, T. (2017). Understanding and management of epilepsy in a rural community
in South Africa: an exploratory study. J. Psychol. Africa, 27(1), 80–83
NCSS (2014). Geometric Regression, 1–35
Ngugi, A. K., Bottomley, C., & Mung'ala-Odera, V. (2023). Global burden of epilepsy and access
to care in low-resource settings. The Lancet Global Health, 11(4)
Ngugi, A. K. (2013). Prevalence of active convulsive epilepsy in sub-Saharan Africa and
associated risk factors: cross-sectional and case-control studies. Lancet. Neurol., 2(3), 253–263
Nyame, P. K., & Biritwum, R. B. (1997). Epilepsy: Knowledge, attitude and practice in literate
urban population, Accra, Ghana. West African Journal of Medicine, 16(3)
Puteikis, K. (2021). Pandemics and burden of stroke and epilepsy in sub-saharan africa:
Experience from a longstanding health programme. Int. J. Environ. Res. Public Health, 18(9), 1–19
Puteikis K, & Mameniškienė, R. (2021). Mortality among People with Epilepsy: A Retrospective
Nationwide Analysis from 2016 to 2019. Int J Environ Res Public Health, 18(19)
Ryvlin, P., Cross, J. H., & French, J. A. (2023). New horizons in epilepsy management: From
novel therapies to AI-assisted diagnostics. Lancet Neurology, 22(2), 139-152
Shah, A., Sengupta, S., & Manford, M. (2023). Epilepsy surgery in the age of neurotechnology:
Emerging techniques and ethical considerations. Journal of Neurosurgery, 139(5), 1250-1258
Shaju, M. & Abraham, S. (2013). Innovations in epilepsy management - An overview. J. Pharm.
Pharm. Sci., 16(4),564–576
Sottie, C., Edith. A. A. &Ta run, D. (2018). Fight-Against the Epielpsy Initiative in Ghana
Singh, T., Dhiman, A., & Verma, R. (2024). AI-based approaches for seizure prediction:
Innovations and future prospects. Artificial Intelligence in Medicine, 149, 102615
Strober, L. B. (2018). Assessment of depression in epilepsy: The utility of common and disease-
specific self-report depression measures. Clin. Neuropsychol., 32 (4), 681–699
Strzelczyk, A., & Reese, J. P. (2016). The economic impact of epilepsy: A systematic review.
Epilepsia, 57(3), 348–358
Strzelczyk, A., Rosenow, F., & Bauer, S. (2023). Innovative therapies for drug-resistant epilepsy:
New pharmacological approaches and perspectives. Epilepsy & Behavior, 145
Sugandha, K. G., Seth, A. M., Arthur, C. G., Jeffrey, G. & Gonzalez, L. N. (2021) Relationships
among illness representations and depressive symptom severity in predominantly African-American and Caribbean-American people with epilepsy. Taylor Fr. Gr. (Multi-Disciplinary)
Teferi, J., Shewangizaw, Z., & Tadesse, S. (2020). Public knowledge and attitude towards epilepsy
and its associated factors: Community-based cross-sectional study, Ethiopia, 2019. Neuropsychiatric Disease and Treatment, 16, 781-788
Thijs, R. D., Surges, R., O'Brien, T. J., & Sander, J. W. (2023). Sudden unexpected death in
epilepsy: Reducing mortality through risk factor identification and management. Epilepsia Open, 8(1), 12-21
Velez-Ruiz, N. J., & Shellhaas, R. A. (2023). Seizure treatment and outcomes in infants: Current
landscape and new horizons. Journal of Clinical Neurophysiology, 40(1), 14-22.
Wang, K and Yang, L. (2012). Geometric Linear Regression and Geometric Relations. Lect. Notes
Comput. Sci. (including Subser. Lect. Notes Artif. Intell. Lect. Notes Bioinformatics), 7389 LNCS, 236–243
WHO. (2019). Global Epilepsy Report 2019. Available: www.who.int/news-room/fact-
sheets/detail/epilepsy
WHO. (2022). Improving the lives of people with epilepsy: Technical brief.
https://www.who.int/publications/i/item/improving-the-lives-of-people-with-epilepsy
Xiao, H., & Pan, Z. (2023). Epilepsy and the gut-brain axis: Exploring microbiome-targeted
therapies. Trends in Neurosciences, 46(7), 475-487
Younes, K., Staley, K., & Verhoog, Q. (2024). Advances in gene therapy for epilepsy: Overcoming
challenges and future directions. Epilepsy Research, 195, 107005
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 AFRICAN JOURNAL OF APPLIED RESEARCH
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
By submitting and publishing your articles in the African Journal of Applied Research, you agree to transfer the copyright of the Article from the authors to the Journal ( African Journal of Applied Research).